{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-104368","form_type":"8-K","ticker":"BRNS","cik":"0001828185","company_name":"Barinthus Biotherapeutics plc.","filed_at":"2026-09-01T21:13:23+00:00","discovered_at":"2026-09-01T21:14:16.416900+00:00","generated_at":"2026-09-01T21:14:19.919801+00:00","sec_items":["3.01","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Barinthus Biotherapeutics: Court sanctions scheme; merger effective Sept 9, trading halt ahead","bullets":["Court sanctioned Scheme of Arrangement and share premium capital reduction on Sept 1, 2026.","Scheme expected to become effective Sept 9, 2026; ADS trading halt expected before open that day.","Merger with Clywedog Therapeutics (per Sept 29, 2025 agreement) on track; delisting/deregistration plans unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-104368","json":"https://secwatch.observer/filing/0001104659-26-104368.json","markdown":"https://secwatch.observer/filing/0001104659-26-104368.md","text":"https://secwatch.observer/filing/0001104659-26-104368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/0001104659-26-104368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/tm2624619d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T21:14:19.919801+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}